AI assistant
Sending…
Sunshine Biopharma Inc. — Director's Dealing 2021
Feb 16, 2021
35352_dirs_2021-02-16_fd330993-67c3-48c3-8550-5f925345c351.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Sunshine Biopharma, Inc (SBFM)
CIK: 0001402328
Period of Report: 2021-01-06
Reporting Person: Slilaty Steve N. (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-06 | Common Stock | A | 20000000 | $0.001 | Acquired | 23343461 | Direct |
More from Sunshine Biopharma Inc.
Share Issue/Capital Change
2026
May 29
Capital/Financing Update
2026
May 19
Share Issue/Capital Change
2026
May 19
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
Apr 9
Annual Report
2026
Apr 3
Declaration of Voting Results & Voting Rights Announcements
2026
Feb 20
Board/Management Information
2026
Feb 5
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 12
Interim / Quarterly Report
2025
Nov 13